|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 7/02 | (2006.01) |
| A61P 29/00 | (2006.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/5377 | (2006.01) |
| (11) | Number of the document | 3065707 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14793578.7 |
| Date of filing the European patent application | 2014-11-06 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/073886 |
| Date | 2014-11-06 |
| (87) | Number | WO 2015/067682 |
| Date | 2015-05-14 |
| (30) | Number | Date | Country code |
| 13005247 | 2013-11-07 | EP |
| (72) |
PRINDERRE, Pascal , FR
|
| (73) |
Siegfried AG ,
Untere Brühlstrasse 4, 4800 Zofingen,
CH
|
| (54) | MESOPOROUS DOSAGE FORMS FOR POORLY SOLUBLE DRUGS |
| MESOPOROUS DOSAGE FORMS FOR POORLY SOLUBLE DRUGS |